Home » FOREST LABS, SPAIN'S ALMIRALL IN DRUG DEVELOPMENT PACT
FOREST LABS, SPAIN'S ALMIRALL IN DRUG DEVELOPMENT PACT
April 10, 2006
Forest Laboratories Inc. and closely held, Barcelona-based pharmaceutical company
Almirall agreed to develop, market and distribute the Spanish company's chronic
obstructive pulmonary disease treatment, LAS34273, in the U.S.